Flolan is a brand name of epoprostenol, approved by the FDA in the following formulation(s):
FLOLAN (epoprostenol sodium - injectable; injection)
Manufacturer: GLAXOSMITHKLINE LLC
Approval date: September 20, 1995
Strength(s): EQ 0.5MG BASE/VIAL [RLD][AP], EQ 1.5MG BASE/VIAL [RLD][AP]
Has a generic version of Flolan been approved?
Yes. The following products are equivalent to Flolan:
epoprostenol sodium injectable; injection
Manufacturer: TEVA PARENTERAL
Approval date: April 23, 2008
Strength(s): EQ 0.5MG BASE/VIAL [AP], EQ 1.5MG BASE/VIAL [AP]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Flolan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Flolan.
See also...
- Flolan Consumer Information (Wolters Kluwer)
- Flolan Consumer Information (Cerner Multum)
- Flolan Advanced Consumer Information (Micromedex)
- Flolan AHFS DI Monographs (ASHP)
- Epoprostenol Consumer Information (Wolters Kluwer)
- Epoprostenol Consumer Information (Cerner Multum)
- Epoprostenol Intravenous Advanced Consumer Information (Micromedex)
- Epoprostenol Sodium AHFS DI Monographs (ASHP)
No comments:
Post a Comment